title: Quality of Life of Patients With Pyoderma Gangrenosum and Hidradenitis Suppurativa.
abstract: BACKGROUND
  Pyoderma gangrenosum (PG) and hidradenitis suppurativa (HS) are painful and unsightly dermatologic disorders that have the potential to significantly decrease patients' quality of life (QOL). Due to the difficulties associated with curing these conditions, QOL improvement is imperative.
  
  
  OBJECTIVE
  To determine if there are PG and HS disease-specific QOL measures and to assess whether QOL is being systematically studied in clinic populations or clinical trials.
  
  
  METHODS
  A PubMed search was performed to identify QOL studies for patients with PG and HS. Sources from other papers were also utilized.
  
  
  RESULTS
  QOL is rarely qualitatively or quantitatively assessed in HS and PG studies. We identified no validated disease-specific QOL measures for either PG or HS.
  
  
  CONCLUSIONS
  Development of disease-specific QOL indices, clinical use of QOL measurement tool, and formal QOL evaluation in clinical trials would help to define the impact of PG and HS treatment in patients' lives.
authors.affiliation: Center for Dermatology Research, Departments of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
authors.forename: Arielle J
authors.initials: AJ
authors.lastname: Gerard
authors.affiliation: Center for Dermatology Research, Departments of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA Departments of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA Departments of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA sfeldman@wakehealth.edu.
authors.forename: Steven R
authors.initials: SR
authors.lastname: Feldman
authors.affiliation: Center for Dermatology Research, Departments of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA Clinical Associates, Baltimore, MD, USA.
authors.forename: Lindsay
authors.initials: L
authors.lastname: Strowd
mesh_terms: D017497:Hidradenitis Suppurativa / Q000503:physiopathology* / Q000523:psychology*; D006801:Humans; D011594:Psychometrics / Q000379:methods; D017511:Pyoderma Gangrenosum / Q000503:physiopathology* / Q000523:psychology*; D011788:Quality of Life
keywords: Verneuil disease; acne inversa; care quality; dermatology; inflammatory; psychophysical; psychosocial